Summary Adjuvant psychological therapy (APT) is a newly developed cognitive behavioural treatment which has been designed specifically to improve the quality of life of cancer patients by alleviating emotional distress and inducing a fighting spirit. We report a phase I/II study which evaluates APT in routine clinical practice. A consecutive series of 44 outpatients with various cancers referred for psychiatric consultation and receiving APT at the Royal Marsden Hospital was studied. Standardised self-report questionnaires were used to measure anxiety, depression and four principal categories of mental adjustment to cancer, namely, fighting spirit, helplessness, anxious preoccupation and fatalism. Statistical comparisons between pre-therapy scores and scores after an average of five APT sessions revealed significant improvement in anxiety, depression, fighting spirit, anxious preoccupation and helplessness. Fatalism scores showed the same trend, but the changes were smaller. Patients with advanced disease showed as much improvement as those with local or locoregional disease. Present results indicate improvement in both psychiatric symptoms and mental adjustment to cancer associated with APT. Whether this association is causal remains to be determined by randomised controlled trials. Such a trial is in progress.
Psychological and social morbidity among cancer patients has been well documented in several systematic studies (Morris et al., 1977; Plumb & Holland, 1977; Maguire et al., 1978; Derogatis et al., 1983; Hughes, 1987) . Such morbidity may persist for years in long-term survivors even in the absence of any signs of disease (Fobair et al., 1986) . Increasing concern about the quality of life of cancer patients has led, recently, to the development of psychological treatment programmes for these patients. Like all treatments in medicine, such psychotherapeutic procedures should be scientifically evaluated by means of randomised controlled trials. The few randomised trials reported so far have produced inconsistent results, reflecting differences in patient populations, in types of psychological treatment and in measures of outcome (Greer, 1989) . Certain methodological problems inherent in psychotherapy trials have been identified; though complex and difficult, these problems are not insurmountable (Cawley, 1983; Moorey & Greer, 1989) .
The requirements of well-designed trials often lead to study designs which are methodologically rigorous but not directly applicable to clinical practice. Highly specific homogeneous patient samples, screened populations and extensive exclusion criteria may contribute to a marked discrepancy between the experience of patients entering a randomised trial and that obtaining in clinical practice. We are at present conducting a randomised trial of adjuvant psychological therapy (see below). Patients with primary cancers or first recurrence are being screened psychologically by means of standardised questionnaires. Those patients who have high scores indicating psychological morbidity are invited to take part in our trial and, if they agree, are randomised to either therapy or a no therapy control group. Compare this with normal clinical practice at the same hospital: patients who, at medical consultation, appear unduly anxious, depressed or otherwise emotionally distressed are referred by their clinicians to the Psychological Medicine department. Hence, although patients receive adjuvant psychological therapy (APT) whether in the trial or clinically referred, the ways in which they come to therapy differ widely.
In addition to research which evaluates APT in patients discovered to have psychological disturbance through screening methods, there is a place for evaluation of its efficacy in clinically referred patients. Clearly, on ethical grounds it would be undesirable to allocate such patients to a noCorrespondence: S. Greer. Received 22 March 1990; and in revised fonn 8 August 1990. treatment control group. As a first step in demonstrating the effectiveness of APT, there is a place for uncontrolled studies of psychological therapy for clinically referred cancer patients. This kind of study should then be followed by randomised controlled trials in which APT is compared with no treatment and, possibly, with other forms of psychological therapy. The present study reports an uncontrolled evaluation of APT in routine clinical practice: anxiety, depression and mental adjustment to cancer among patients referred for psychiatric consultation are compared before and after APT.
Materials and methods
A consecutive series of out-patients with a confirmed diagnosis of cancer referred for psychiatric consultation at The Royal Marsden Hospital was studied. Patients were entered in the trial: (i) if they were suffering from a formal psychiatric disorder (excluding organic mental disorders, schizophrenia and other psychotic disorders); or (ii) if their psychological disturbance, though not reaching the level of a formal psychiatric disorder, was sufficiently severe to have resulted in more than transient distress. All patients referred during a specified period who fulfilled these criteria were entered in the study.
Adjuvant psychological therapy (APT)
A full description of APT has been provided by Moorey and Greer (1989) . APT is a brief structured treatment programme in which the principles of cognitive therapy are applied to the specific problems of cancer patients. Cognitive therapy aims to alleviate emotional disorders by identifying and correcting maladaptive thinking (Beck, 1976 (Greer & Watson, 1987; Watson et al., 1988 (i) Anxiety scores at 8 weeks: no effects were found for sex (F = 0.32; d.f. = 1; P = 0.58), performance status (F = 0.58; d.f. = 1; P = 0.45), breast cancer versus other diagnoses (F = 0.00; d.f. = 1; P = 0.96), presence of symptoms referrable to chemo/radiotherapy, primary versus recurrent disease (F = 0.40; d.f. = 1; P = 0.53). Stage of disease just failed to reach significance (F = 2.97; d.f. = 2; P = 0.06).
(ii) Depression scores at 8 weeks: no effects were found for sex (F = No significant effects of interaction were found for any of these analyses. Flexibility is also required when planning the duration of therapy. Although we aimed to have weekly sessions, several patients could not attend each week either on medical grounds or because they lived a long distance from the hospital; hence, the number of APT sessions during the 8 week assessment period varied from two to eight, the average being five sessions. For obvious reasons, prolonged psychotherapy is neither feasible nor appropriate for most cancer patients. APT has been designed as a short-term therapy. It follows that, if therapy is successful, measurable psychological benefit should occur within a brief period. In the present feasibility study, we have taken 8 weeks after commencement of therapy as the assessment point, irrespective of the number of sessions or whether therapy had been completed.
Our results show a significant reduction in anxiety and depression 8 weeks after APT had been commenced. Outcome was measured by patient self-rating scales in order to obviate bias inherent in clinical assessments by the therapists. The HAD scale was used to measure anxiety and depression. We have found, in a study of 568 patients with cancer, that factor analysis produced two distinct though correlated factors corresponding to the questionnaire's anxiety and depression subscales (Moorey et al., 1991) . These results confirm that the separate subscales of the HAD scale should be used. We believe that these studies provide a firm basis for the use of the HAD scale as a measure of anxiety and depression in patients suffering from cancer. In the present series of emotionally distressed patients, 86% were correctly identified by high anxiety or depression scores; the remaining 14% (six patients) scored in the normal range on both subscales.
Statistically significant improvement in anxiety and depression was observed 8 weeks after commencement of APT when patients had received an average of five sessions. At the 8 weeks assessment, nearly half the patients were deemed to have completed therapy. The observed reductions in anxiety and depression were not merely statistically significant changes in mean scores but represented clinically significant improvement. The proportion of patients with high anxiety scores fell from 84% (n = 37) before therapy to 48% (n = 21) at final assessment. Depression was less common in our patients, but the same trend was observed: the proportion of patients with high depression scores dropped from 50% (n = 22) before therapy to 25% (n = 11). It should be noted that no patient became worse as a result of therapy.
Mental adjustment to cancer, measured by the MAC scale, also improved. At 8 weeks assessment, significant decreases in helplessness and anxious preoccupation and a significant increase in fighting spirit were demonstrated. These changes have a beneficial effect on quality of life. Active coping strategies, as subsumed under the heading of fighting spirit, have been shown to be the most effective in managing the stress of breast cancer (Rowland & Holland, 1989) . Conversely, helplessness and anxious preoccupation are correlated with depression and anxiety (Watson et al., 1988) .
We found no significant predictors of psychological outcome except, as might be expected, pre-therapy anxiety and depression scores; high pre-therapy scores were correlated with high scores at 8 weeks. It is worthy of note that neither disease stage nor performance status predicted psychological outcome suggesting that patients with metastatic as well as local and locoregional disease can benefit from APT. It should be noted, however, that the present patient sample did not include any severely disabled patients, i.e. those with WHO performance status 3 and 4.
The present study has established the feasibility of APT in a cancer hospital and demonstrated significant improvement in anxiety, depression and mental adjustment to cancer following a brief course (averaging five sessions) of APT. This phase I/II study cannot, of course, determine whether APT was responsible for the observed improvement in quality of life. But our results are sufficiently encouraging to mount a controlled trial of APT.
